Medications commonly used to treat Alzheimer’s disease may have another benefit: they may reduce the risk of having a heart attack. Drugs like donepezil (brand name Aricept), rivastigmine (Exelon) and galantamine (Reminyl) are commonly given to those in the earlier … Continue reading →
Fisher Scientists Discover New Ways to Rid Cells of Alzheimer’s Protein Beta-amyloid is a protein that causes Alzheimer’s disease when toxic forms of it accumulate in the brain. Two years ago Fisher Center scientists discovered that nerve cells are able … Continue reading →
Having low levels of leptin, a hormone that regulates appetite, is linked to an increased risk of Alzheimer’s disease in people who have memory problems, according to a new report. The findings confirm earlier reports that leptin, which like other … Continue reading →
A cancer drug called bexarotene failed to live up to its early promise in treating the brain plaques of Alzheimer’s disease, though the drug did show some benefits in improving memory in animal studies. The mixed findings highlight the difficulty … Continue reading →
A new study provides reassurance to the millions of people who must undergo major surgery each year: general anesthesia does not appear to lead to an increased likelihood of developing Alzheimer’s disease or other forms of dementia. The findings, published … Continue reading →
A Fun Social Network Environment for those in the Alzheimer's Community!
The Fisher Center for Alzheimer's Research Foundation
199 Water Street, 23rd Floor
New York, NY 10038
Toll Free: 1-800-ALZ-INFO or 1-800-259-4636 Email: email@example.com
This project was supported, in part, by a grant, number 90AZ2791, from the Administration on Aging, Department of Health and Human Services, Washington, D.C. 20201. Grantees undertaking projects under government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not, therefore, necessarily represent official Administration on Aging policy.